Home > Insider Trading > Filing (0001209191-19-050745)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1067586	J Randall Steward	12544 High Bluff Drive, Suite 200 San Diego CA 92130	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-23	29,328	$15.40	48,787	No	4	M	Direct
Common Stock	Disposition	2019-09-23	29,328	$62.60	19,459	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Disposition	2019-09-23	29,328	$0.00	29,328	$15.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,775		2026-02-10	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $62.6037 per share, with a range of $61.84 to $64.25. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
19,552 shares vested on 2/10/2018; 9,776 shares vested on 2/10/2019; and 9,775 shares will vest on 2/10/2020.